PT - JOURNAL ARTICLE AU - Zhou, Juexiao AU - He, Xiaonan AU - Sun, Liyuan AU - Xu, Jiannan AU - Chen, Xiuying AU - Chu, Yuetan AU - Zhou, Longxi AU - Liao, Xingyu AU - Zhang, Bin AU - Gao, Xin TI - SkinGPT-4: An Interactive Dermatology Diagnostic System with Visual Large Language Model AID - 10.1101/2023.06.10.23291127 DP - 2023 Jan 01 TA - medRxiv PG - 2023.06.10.23291127 4099 - http://medrxiv.org/content/early/2023/06/13/2023.06.10.23291127.short 4100 - http://medrxiv.org/content/early/2023/06/13/2023.06.10.23291127.full AB - Skin and subcutaneous diseases rank high among the leading contributors to the global burden of nonfatal diseases, impacting a considerable portion of the population. Nonetheless, the field of dermatology diagnosis faces three significant hurdles. Firstly, there is a shortage of dermatologists accessible to diagnose patients, particularly in rural regions. Secondly, accurately interpreting skin disease images poses a considerable challenge. Lastly, generating patient-friendly diagnostic reports is usually a time-consuming and labor-intensive task for dermatologists. To tackle these challenges, we present SkinGPT-4, which is the world’s first interactive dermatology diagnostic system powered by an advanced visual large language model. SkinGPT-4 leverages a fine-tuned version of MiniGPT-4, trained on an extensive collection of skin disease images (comprising 52,929 publicly available and proprietary images) along with clinical concepts and doctors’ notes. We designed a two-step training process to allow SkinGPT-4 to express medical features in skin disease images with natural language and make accurate diagnoses of the types of skin diseases. With SkinGPT-4, users could upload their own skin photos for diagnosis, and the system could autonomously evaluate the images, identifies the characteristics and categories of the skin conditions, performs in-depth analysis, and provides interactive treatment recommendations. Meanwhile, SkinGPT-4’s local deployment capability and commitment to user privacy also render it an appealing choice for patients in search of a dependable and precise diagnosis of their skin ailments. To demonstrate the robustness of SkinGPT-4, we conducted quantitative evaluations on 150 real-life cases, which were independently reviewed by certified dermatologists, and showed that SkinGPT-4 could provide accurate diagnoses of skin diseases. Though SkinGPT-4 is not a substitute for doctors, it could enhance users’ comprehension of their medical conditions, facilitate improve communication between patients and doctors, expedite the diagnostic process for dermatologists, and potentially promote human-centred care and healthcare equity in underdeveloped areas.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJuexiao Zhou, Xiuying Chen, Yuetan Chu, Longxi Zhou, Xingyu Liao, Bin Zhang, and Xin Gao were supported in part by grants from the Office of Research Administration (ORA) at King Abdullah University of Science and Technology (KAUST) under award number FCC/1/1976-44-01, FCC/1/1976-45-01, REI/1/5202-01-01, REI/1/5234-01-01, REI/1/4940-01-01, RGC/3/4816-01-01, and REI/1/0018-01-01. Xiaonan He was supported by the foundation of the National Natural Science Foundation of China (No. 62272327).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of King Abdullah University of Science and Technology gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors